Glen Rock New Jersey based RespireRx Pharmaceuticals is raising $2,000,000.00 in New Equity and Debt Financing.
Glen Rock, NJ – According to filings with the U.S. Securities and Exchange Commission, RespireRx Pharmaceuticals is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Jeff Margolis played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About RespireRx Pharmaceuticals
RespireRx Pharmaceuticals Inc. (formerly Cortex Pharmaceuticals, Inc.) is a biopharmaceutical company developing innovative and revolutionary treatments to combat disorders caused by disruption of neuronal signaling. We are focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression, and other brain-mediated breathing disorders. .
To learn more about RespireRx Pharmaceuticals, visit http://respirerx.com/
Contact:
Jeff Margolis, Chief Financial Officer
201-444-4947
jmargolis@respirerx.com
https://www.linkedin.com/in/jeff-margolis-b501114/
SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved